Global Peritoneal Dialysis Market Overview:
The Global Peritoneal Dialysis Market generated $3,213 million in 2017, and is projected to reach $5,074 million by 2025, growing at a CAGR of 5.8% from 2018 to 2025. Peritoneal dialysis (PD) is a form of dialysis that uses the inner lining of the abdomen and dialysis solution to filter blood when the kidney is not functioning effectively. This procedure is mostly performed at home and primarily works to remove excess fluid and waste products from the blood.
Factors such as increase in awareness about automated peritoneal dialysis, technological advancement in peritoneal dialysis cyclers, rise in prevalence of end stage renal disease (ESRD), and surge in demand for home dialysis treatment are expected to boost the growth of the peritoneal dialysis market during the forecast period. In addition, peritoneal dialysis offers some advantages such as, low cost as compared to hemodialysis, needle free treatment, portability, treatment convenience, and few dietary restrictions, further drive the market growth globally. However, risk associated with peritoneal dialysis such as peritonitis, infection, weight gain, and hernia are expected to impede the market growth.
Peritoneal Dialysis Market Segmentation
The global peritoneal dialysis market is segmented based on treatment type, product type, end user, and region. Based on treatment type, the market is classified as continuous ambulatory peritoneal dialysis (CAPD) and automated peritoneal dialysis (APD). Based on product type the market is segmented as peritoneal dialysis solution, device, peritoneal dialysis set, catheter, and others. According to end user, the market is divided into home-based dialysis, and dialysis center & hospital based dialysis. Based on region, the market is studied across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
Segment Review
Based on treatment type, the peritoneal dialysis market is segmented as continuous ambulatory peritoneal dialysis (CAPD) and automated peritoneal dialysis (APD). At present, CAPD is the major revenue generating segment due to low cost, portability, and freedom from machines. On the other side, APD is estimated to exhibit fastest market growth during the forecast period owing to its advantages such as flexibility with daytime routine, safety, and convenience.
According to product type, the market is segmented as peritoneal dialysis solution, device, peritoneal dialysis set, catheter, others. At present, the market is dominated by the peritoneal dialysis solution segment and is anticipated to show dominance during the forecast period. Peritoneal dialysis solution plays a vital role in every PD procedure as solutions are required for the exchange of fluid when the kidney is not functioning effectively. On the other side, the device segment is expected to exhibit the fastest market growth during the forecast period, due to the technological advancement in devices and increase in demand for automated peritoneal dialysis (APD).
Snapshot of Asia-pacific Peritoneal Dialysis Market
Asia-Pacific presents lucrative opportunities for the key players operating in the peritoneal dialysis market, owing to high population base, development in healthcare infrastructure, rapid rise in prevalence of end stage renal disease (ESRD), growth in demand for home dialysis treatment, and increase in demand for advanced PD devices. However, as insurance companies do not cover the entire treatment expenses for dialysis, it is estimated to hamper the market growth in Asia-Pacific.
The key players profiled in this report include Baxter International Inc., Cook Inc., Fresenius Medical Care AG & Co. KGaA, Medionics International, Inc., Medtronic Plc., Newsol Technologies Inc., Poly Medicure Limited, Renax Biomedical Tech. Co., Ltd., Terumo Corp., and Utah Medical Products, Inc.
Key Benefits
- The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.
- It offers a quantitative analysis from 2017 to 2025, which is expected to enable the stakeholders to capitalize on the prevailing market opportunities.
- A comprehensive analysis of all the geographical regions is provided to determine the prevailing opportunities.
- The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global market.
Peritoneal Dialysis Market, by Treatment Type Report Highlights
| Aspects | Details |
 By TREATMENT TYPE |
|
 By PRODUCT |
|
 By END USER |
|
 By Region |
|
 Key Market Players | Fresenius Medical Care AG & Co. KGaA, Medionics International, Inc, Newsol Technologies Inc, Utah Medical Products, Inc, Cook Medical Inc, Poly Medicure Ltd, Medtronic Plc, Baxter International Inc, Renax Biomedical Tech. Co., Ltd, Terumo Corporation |
Analyst Review
Peritoneal dialysis (PD) is a treatment that uses the inner lining of abdomen called peritoneum and a dialysis solution to clean blood when the kidneys are not functioning adequately. PD is performed manually or via automated systems. The adoption of peritoneal dialysis is expected to increase due to rise in the prevalence of end stage renal disease (ESRD) and growth in demand for home dialysis treatment.
The technological advancement in PD devices & cyclers, and growth in demand for automated peritoneal dialysis in the developing countries are projected to supplement the market growth during the forecast period. In addition, great flexibility in the treatment schedule, convenience, needle-free treatments, short hospital stay, and few dietary restrictions are some other factors supporting the market growth. However, complications associated with the treatment of peritoneal dialysis such as infection, hernia, and peritonitis hinder the market growth.
North America is expected to remain dominant during the forecast period due to surge in prevalence of ESRD and high demand for automated peritoneal dialysis (APD). In addition, Asia-Pacific and LAMEA are expected to offer lucrative opportunities to the key players during the forecast period.
Loading Table Of Content...
